Skip to main content
. Author manuscript; available in PMC: 2009 Sep 15.
Published in final edited form as: Clin Cancer Res. 2008 Sep 15;14(18):5656–5662. doi: 10.1158/1078-0432.CCR-08-0123

Table 1.

Summary of targeting strategies to inhibit IKK activity

Strategies Potential targets Therapeutic agents References
Small molecule inhibitors IKKα/β PS-1145 Castro et al. (44), Hideshima et al. (45)
BMS-345541 Burke et al. (46), McIntyre et al. (47)
SPC-839 Palanki et al. (48)
CHS828 Hiarnaa et al. (51), Olsen et al. (52)
IKKβ ML120B Wen et al. (49)
SC-514 Kishore et al. (50)
TBK1 SU6668 Godl et al. (39)
RNA interference and small interfering RNAs IKKα/β/ε and TBK1 Takaesu et al. (54)
Gene therapy IKKβ E1A Shao et al. (55, 56)
Cell-permeable peptides IKKα/β/γ complex IKKβ [644–756] peptide May et al. (61)